Dr McCartney argues we need to tackle how the world we live in fuels obesity rather than "expecting" people to put on weight "and then accept a medical intervention to treat it"
GLP1 Drugs (Wegovy, Zepbound): Pros: Highly effective, non-invasive, strong appetite suppression, rapid results
Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials
Magnitude matters: Were now routinely discussing 1020%+ weight loss targets, because thats where many obesity complications start meaningfully improving (metabolic, functional, hepatic)
Retatrutide is in late-stage clinical trials
Why Klinic in Memphis Prescribes Alternatives to Ozempic for Weight Loss Though Ozempic and Wegovy share semaglutide, their purposes differ significantly